Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James E. Levine currently holds 200,000 shares of Cidara Therapeutics, Inc. (CDTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James E. Levine has been a net buyer of CDTX stock. They have purchased $721.1K and sold $0 worth of shares.
James E. Levine's most recent insider trade was on Jun 19, 2026, when they sold 200,000 shares at $0.00 per share.
James E. Levine serves as Executive at Cidara Therapeutics, Inc. (CDTX). They have executed 20 insider transactions totaling $721.1K over their tenure at the company.
James E. Levine holds the position of Executive at Cidara Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
James E. Levine has shown a buying trading pattern, with $721.1K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by James E. Levine was on Oct 31, 2013, when they sold $436.7K worth of VRNM shares. This transaction involved 109,166 shares at $4.00 per share.
James E. Levine currently owns 200,000 shares of Cidara Therapeutics, Inc. (CDTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James E. Levine's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James E. Levine has 20 Form 4 filings on record as an insider at Cidara Therapeutics, Inc..
Set alerts for James E. Levine and 40,000+ other insiders.